Biotechnology
Enzymes
Development
Commercialization
Unitedstates
Stock
Offering
Industrial
M&A Advisory
Lazard
Full Credential Description
Verenium. United States. Announced Date 06/10/2009. Closed Date 09/10/2009. Deal value: $14m. Registered direct offering of common stock and warrants. Industry: Verenium is a biotechnology company specializing in the development and commercialization of high-performance enzymes for industrial processes.